In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant <i>Stenotrophomonas maltophilia</i>.

Wu, Jie; Zhang, Guangcun; Zhao, Qiang; Wang, Lifeng; Yang, Jiyong; Cui, Junchang

In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia.

Wu, Jie; Zhang, Guangcun; Zhao, Qiang; Wang, Lifeng; Yang, Jiyong; Cui, Junchang.

Afiliação

Wu J; Department of Respiratory Diseases, The Eighth Medical Center, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Zhang G; Medical School of Chinese People's Liberation Army, Beijing, People's Republic of China.
Zhao Q; Laboratory Medicine Department, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Wang L; Laboratory Medicine Department, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Yang J; Laboratory Medicine Department, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.
Cui J; Laboratory Medicine Department, The First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China.

Infect Drug Resist ; 16: 6005-6015, 2023.

Article em En | MEDLINE | ID: mdl-37705512